What About Vitamin B12 Injections
No, Botox and dermal fillers are safe to receive while taking GLP-1 medications
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Common signs include reduced sexual desire, fatigue, decreased muscle mass, increased body fat, and mood disturbances such as depression or irritability
Analytical Identity BPC-157 (CAS 137525-51-0) is supplied as a laboratory research reference material intended strictly for in-vitro and laboratory research use
Using a USB camera (Veho discovery VMS-004 deluxe) attached to a microscope, we recorded the vessel presentation for the 15 min immediately following treatment, as described above
